Legend Biotech Corp - Bathi resik saben saham sajrone 12 wulan pungkasan LEGN

Legend Biotech Corp. (LEGN) - logo korporat

The effective alliance with J&J regarding CARVYKTI confirms the managerial success of Legend Biotech (LEGN). The 12-month YoY change in net income per share reflects this trend, where the parameter value equals 99.00. Stability is maintained by a staff of top biologists attracted by stock options, while the high cost of therapy, covered by insurance, guarantees the company exceptional pricing power.

legendbiotech.com (LEGN): Bathi saben saham sajrone rolas wulan pungkasan saka 11.02.2024 nganti 12.11.2026

Rincian metrik keuangan lan pasar Legend Biotech Inc. (LEGN)

Pambiji fundamental perusahaan:LEGN legendbiotech.com
Barang unggulan Legend Biotech Corp.

An investment audit of Legend Biotech (LEGN) requires an analysis of profit dynamics, where the annual growth of basic net income per share (TTM) measures the percentage change in EPS over a rolling year relative to the previous period. This metric reflects the scaling efficiency of automated gene therapy production, allowing this chart to assess the extent to which the technological sterility of bioreactors converts into real growth in shareholder value.